HB0025

Other Medications

1 Clinical Trials

Description

HB0025 is an investigational medication currently being studied in clinical trials for various advanced solid tumors, including non-small cell lung cancer (NSCLC) and endometrial cancer. It is being evaluated in combination with standard chemotherapy regimens (like carboplatin, paclitaxel, pemetrexed). The trials are primarily focused on assessing the safety and determining the appropriate dose of HB0025. While the trials listed include patients with specific gene mutations (ALK, BRAF, EGFR, RET, ROS1), the primary goal of the current phase 1 trials is dose finding and safety assessment, not specifically targeting these mutations. The role of HB0025 in colorectal cancer is not explicitly mentioned in the provided trial information, but it is being studied in advanced solid tumors generally.

Mechanism of Action

HB0025 is being studied in combination with chemotherapy. The specific mechanism of action of HB0025 is not fully detailed in the provided information, but it is being investigated in clinical trials. It is administered intravenously.

Side Effects

As HB0025 is an investigational drug in early-phase trials (Phase 1) The full range of potential side effects is still being evaluated. The safety and tolerability of HB0025 Especially when combined with chemotherapy Are key aspects being studied in the current trials. Common side effects associated with the chemotherapy regimens used in the trials (carboplatin Paclitaxel Pemetrexed) may include nausea Vomiting Fatigue Hair loss Low blood counts And peripheral neuropathy. Specific side effects related to HB0025 itself are still being determined.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06758557 Phase 1
Recruiting
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
China

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
786 trials
Leucovorin
Other Medications
647 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.